Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Working Capital/Sales

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Working Capital/Sales(x) 3.704.375.174.845.27

What is the latest Working Capital/Sales ratio of NEULAND LABORATORIES ?

The latest Working Capital/Sales ratio of NEULAND LABORATORIES is 3.70 based on Mar2023 Consolidated results.
Year Working Capital/Sales
Mar20233.70
Mar20224.37
Mar20215.17
Mar20204.84
Mar20195.27

How is Working Capital/Sales of NEULAND LABORATORIES Trending?

Years Working Capital/Sales % Change
Mar2023 3.7
-15.33
Mar2022 4.37
-15.47
Mar2021 5.17
6.82
Mar2020 4.84
-8.16
Mar2019 5.27 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Working Capital/Sales ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹9,806.5 Cr 7.6% 22% 261.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr -0.1% -6.3% 53.5% Stock Analytics
CIPLA ₹115,034.0 Cr 1% -5% 53.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.1% 2.2% 26% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr 3.2% 15.3% 23.6% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 3.9% -1.7% 85.2% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

7.6%

22%

261.3%

SENSEX

1%

2.2%

23.7%


You may also like the below Video Courses